Join the 200th Anniversary Celebration

Original Article

The Influence of a Family History of Asthma and Parental Smoking on Airway Responsiveness in Early Infancy

Sally Young, B.Sc., Peter N. Le Souëf, M.D., F.R.A.C.P., Gary C. Geelhoed, M.B., B.S., F.R.A.C.P., Stephen M. Stick, M.A., M.B., B.Chir., M.R.C.P.(U.K.), Keven J. Turner, Ph.D., F.R.C.Path., and Louis I. Landau, M.D., F.R.A.C.P.

N Engl J Med 1991; 324:1168-1173April 25, 1991

Abstract
Abstract

Background.

Airway responsiveness to inhaled nonspecific bronchoconstrictive agents has been demonstrated in normal, healthy infants. However, it is unknown whether airway responsiveness is present from birth or if it develops as a result of subsequent insults to the respiratory tract. To investigate this question, we assessed airway responsiveness in 63 normal infants at a mean age of 4 1/2 weeks.

Methods.

Respiratory function was measured with use of the partial forced expiratory flow—volume technique to determine the maximal flow at functional residual capacity (VmaxFRC). The infants inhaled nebulized histamine at sequentially doubled concentrations (0.125 to 8.0 g per liter), until a concentration was reached at which the VmaxFRC fel1 by 40 percent from the base-line value (PC40) or until a concentration of 8.0 g per liter was reached. We also assessed maternal serum levels of IgE, cordserum levels of IgE, the infants' skin reactivity to several allergens, and the parents' responsiveness to histamine and obtained family histories of asthma and smoking.

Results.

Airway responsiveness was increased in infants with a family history of asthma (n = 19; median PC40, 0.78 g per liter; 95 percent confidence interval, 0.44 to 1.15; P<0.01), parental smoking (n = 13; median PC40, 0.52 g per liter; 95 percent confidence interval, 0.43 to 5.40; P<0.05), or both (n = 20; median PC40, 0.69 g per liter; 95 percent confidence interval, 0.37 to 2.10; P<0.05), as compared with the infants with no family history of asthma or smoking. The infants with no family history of asthma or smoking had a median PC40 of 2.75 g per liter (95 percent confidence interval, 1.48 to 4.00). No significant relations were detected between the immunologic variables and the PC40 in the infants.

Conclusions.

This study indicates that airway responsiveness can be present early in life and suggests that a family history of asthma or parental smoking contributes to elevated levels of airway responsiveness at an early age. (N Engl J Med 1991; 324:1168–73.)

Media in This Article

Figure 2Individual Values for the Histamine Concentrations That Provoked a Decrease of 40 Percent in VmaxFRC (PC40).
Figure 1Individual Base-Line Values for VmaxFRC, Expressed as a Percentage of the Predicted Value for Each Group.
Article

ALTHOUGH asthma is considered to result from a complex interaction of genetic and environmental influences, there has been little recent progress in determining their relative contributions.1 Recent developments in the measurement of respiratory function in infants2 have allowed inhalation challenges to be used in this age group in order to obtain objective measurements of airway responsiveness (the ability of the airways to constrict in response to certain stimuli).3 This technique is of particular interest, since airway responsiveness is the most useful objective physiologic measurement associated with the presence of asthma.1

The first inhalation-challenge studies in older normal infants, in which investigators used methacholine,4 cold, dry air,5 or histamine,6 indicated that airway responsiveness was present in infants during the first year of life. Two questions have arisen from these studies. First, how early in infancy is airway responsiveness present? It has been speculated that persons with asthma are not born with heightened airway responsiveness but are born with a tendency to increased responsiveness after an insult to the respiratory system.1 , 7 Second, is the initial level of airway responsiveness the same for all infants, or do genetic or environmental influences, or both, result in differing levels of responsiveness at birth? Specific environmental features, such as viral infections, irritants, and allergens, affect airway responsiveness in older children and adults,1 but their influence on airway responsiveness in infants is unknown.

To investigate these two questions, we undertook a prospective, longitudinal study to determine the presence and level of airway responsiveness and its relation to a family history of asthma or parental smoking in 63 normal infants. This report presents our findings at the first assessment of the infants, at a mean age of 4 1/2 weeks.

Methods

Subjects

Sixty-three infants, 24 girls and 39 boys, were studied at a mean age of 4 1/2 weeks (range, 2 to 10). The criteria for inclusion were full-term gestation and an absence of perinatal problems and major congenital anomalies. At the time of the assessment, none of the infants had previously had a lower respiratory tract infection or any clinically important nonrespiratory illness. No infant had had an upper respiratory tract infection in the preceding three weeks. All infants were well at the time of the study.

The families of all the infants were recruited randomly at the prenatal clinic at Osborne Park Hospital, Perth, Western Australia. This is a peripheral metropolitan hospital with 2000 deliveries per year. The recruitment procedure began with an interview with the mother during a routine prenatal visit, at which time she was given written information on the family involvement that would be required during the proposed 12-month study period. One week after the interview, each family was contacted by telephone to determine whether they would agree to participate in the study. Signed parental consent was obtained for all infants. Over a 12-month period, 241 mothers were interviewed and 63 (26 percent) consented to participate. The study was performed with the approval of the medical ethics committees of Princess Margaret Hospital and the University of Western Australia.

Details of respiratory illness and atopy in the family and parental smoking habits were obtained with use of a modified American Thoracic Society questionnaire8 administered by a single investigator. The 63 infants were divided into four groups on the basis of their family histories of asthma and parental smoking. Those classified as having a family history of asthma were those whose parents reported asthma in primary relatives (the parents and siblings of the infant) or secondary relatives (grandparents, aunts, and uncles). Infants with a family history of smoking were those whose parents reported that either or both had smoked during the pregnancy. The four groups were defined as follows: group 1 (n = 11) — no family history of asthma in primary or secondary relatives, both parents nonsmokers; group 2 (n = 19) — family history of asthma in primary or secondary relatives (or both), both parents nonsmokers; group 3 (n = 13) — no family history of asthma in primary or secondary relatives, one or both parents smoked during the pregnancy; and group 4 (n = 20) — family history of asthma in primary or secondary relatives (or both), one or both parents smoked during the pregnancy. The responses to questions about parental smoking habits after the infant's birth indicated that all parents in groups 1 and 2 remained nonsmokers and the smoking parents in one family in group 3 and one in group 4 ceased smoking after the birth of the infant.

Assessment

Responsiveness to histamine was measured in 75 of the parents by the rapid-inhalation technique of Yan et al.9 To assess immunologic influences on airway responsiveness, IgE was measured in maternal and cord serum10 by the Clinical Immunology Research Unit, Princess Margaret Hospital for Children. Forty-seven pairs of samples of maternal and cord serum were analyzed.

Respiratory function was assessed by the forced expiratory flow-volume method.2 A jacket was rapidly inflated at end inspiration, and flow was measured from the partial expiratory flow-volume curve at functional residual capacity. The jacket pressure was gradually increased over a series of forced expirations until maximal flow at functional residual capacity (VmaxFRC) was obtained. Flow was measured with a No. 1 Fleisch pneumotachygraph (PK Morgan, Chatham, England), a Validyne DP-45 pressure transducer (Northridge, Calif.), and a Validyne CD19 amplifier. Volume values were obtained by electronic integration. The infant breathed through a molded-putty face mask attached to the pneumotachygraph. All signals were recorded on a chart recorder (Linearecorder F Wr 3801, Graphtec, Tokyo); flow and volume were monitored during the study with a Tektronix 5223 digitalizing storage oscilloscope (Beaverton, Oreg.) and recorded on tape (TEAC SR-50, TEAC Corp., Tokyo). Taped signals were transcribed to paper on a Hewlett—Packard 7090A x,y paper plotter (Waltham, Mass.). Arterial oxygen saturation was monitored throughout the study with a Nellcor N-200 E pulse oximeter (Hayward, Calif.). Supplementary oxygen was administered if arterial oxygen saturation fell below 90 percent.

Infants were studied while asleep after they were given a dose of chloral hydrate (80 mg per kilogram of body weight). The minimal jacket pressure required to produce VmaxFRC was established. This pressure was used in all subsequent forced expirations. Respiratory function was assessed before and after the administration of nebulized saline with an Airlife nebulizer (American Pharmaseal, Valencia, Calif.) at 6 liters per minute. This and all other nebulized agents were delivered directly to the face mask and inhaled during one minute of tidal breathing. For the base-line VmaxFRC, we used the mean of the values for five forced expirations after the administration of nebulized saline.

The histamine challenge was carried out by administering sequentially doubling concentrations of nebulized histamine, ranging from 0.125 g per liter to a maximal concentration of 8.0 g per liter, as previously described.6 A new concentration was delivered every five minutes, and respiratory function was assessed after each, with a minimum of five forced expirations at each measurement. The challenge was ended when a response to histamine was recorded or when the maximal concentration was reached. A response was defined as a decrease in the mean VmaxFRC of at least 40 percent from the base-line value. For infants who responded to histamine, the concentration that provoked a 40 percent decrease in VmaxFRC (PC40) was derived by linear interpolation from the plot of the log histamine concentration against the percent decrease in VmaxFRC from base line. The coefficient of repeatability for a histamine challenge to an infant according to this protocol was 3.3 sequentially doubled concentrations.11 We also determined the dose of histamine that provoked a 20 percent decline in the forced expiratory volume in one second in the parents (PD20).

Two investigators measured airway function and determined airway response; one, who operated the equipment, was blinded to the infant's family history; the second, who recorded data on the infant's chart, had recruited the participants and completed the family-history questionnaires and was therefore aware of the family history. Because the blinded investigator identified changes in pulmonary function, no bias was introduced into the results.

Skin reactivity was assessed in all infants on the same day as, but before, the administration of chloral hydrate and the subsequent histamine challenge. The allergens used were Dermalophagoides farinae, perennial ryegrass pollen, cow's milk, and egg white (Hollister—Stier, Elkhart, Ind.). A positive response was defined as a wheal 2 mm or more in diameter.

Statistical Analysis

Differences in base-line values for VmaxFRC and PC40 among the groups were analyzed with use of the Mann—Whitney U test.12 The median and confidence intervals for the median were determined with use of the Confidence Interval Analysis microcomputer program.13 , 14 All values for IgE underwent logarithmic transformation before analysis. Within each family-history group, regressions were used to determine the relation between maternal serum IgE levels and cord-serum IgE levels, maternal serum IgE levels and PC.40, and cord-serum IgE levels and PC40. Maternal serum and cordserum IgE levels in the groups were compared with use of Student's unpaired (two-tailed) t-test.

Results

Descriptive data for the groups of infants are shown in Table 1Table 1Characteristics of the Subjects According to Family-History Group.*. The infants in group 3 had a significantly lower mean birth weight than those in groups 2 and 4. All the mothers of infants in group 3 smoked during the pregnancy. Among the infants in group 4, 16 had mothers who had smoked during the pregnancy and 4 had fathers who had smoked during this time. There were no significant differences between the birth weights of infants in group 4 whose mothers had smoked and those of infants whose fathers (but not their mothers) had smoked or those of the infants in groups 1 and 2.

Base-line lung function for the groups is shown in Figure 1Figure 1Individual Base-Line Values for VmaxFRC, Expressed as a Percentage of the Predicted Value for Each Group.. Base-line VmaxFRC is expressed as a percentage of the predicted value, which was based on the predictive equation of Tepper et al.15 The four groups did not differ significantly in base-line lung function.

Figure 2Figure 2Individual Values for the Histamine Concentrations That Provoked a Decrease of 40 Percent in VmaxFRC (PC40). shows the responsiveness to histamine in the four groups. Individual values for PC40 are given, along with the median value of PC40 for each group. Infants who responded to the first concentration were classified as having a PC40 of less than 0.125 g per liter. Those who had not responded at a concentration of 8.0 g per liter were classified as having a PC40 of more than 8.0 g per liter. PC40 values were not obtained for three infants; two were flow-limited at base line (i.e., forced expiratory flow was no greater than tidal expiratory flow) and therefore were not challenged with histamine (both in group 2), and in the case of one infant in group 4, the challenge was discontinued when upper-airway obstruction developed. Infants in group 1, who had a median PC40 of 2.75 g per liter (95 percent confidence interval, 1.48 to 4.00), were significantly less responsive than those in group 2 (median PC40, 0.78 g per liter; 95 percent confidence interval, 0.44 to 1.15; P<0.01), group 3 (median PC40, 0.52 g per liter; 95 percent confidence interval, 0.43 to 5.40; P<0.05), and group 4 (median PC40, 0.69 g per liter; 95 percent confidence interval, 0.37 to 2.10; P<0.05). There were no significant differences among the values for PC40 in groups 2, 3, and 4.

Of the 33 infants who had one or more parents who smoked during the pregnancy (groups 3 and 4), only 4 had fathers who smoked and nonsmoking mothers. All four were in group 4, where a family history of asthma was also present. We were therefore unable to determine the effect of paternal smoking alone.

Because there were more boys than girls in the group as a whole and because there was a particular disproportion in groups 2 and 4, comparisons of airway function were made on the basis of sex. No significant differences were found in either base-line lung function or airway responsiveness between boys and girls in the entire group of 63 infants or within the four family-history groups.

Of the 63 infants in whom skin reactivity was assessed, 7 had a positive response to one allergen and 1 had a positive response to two allergens. Responses were recorded for each of the four allergens and among infants in all four groups. There was no relation between the incidence of skin reactivity and the degree of responsiveness at this age.

Fourteen of the 75 parents who were tested responded to inhaled histamine. The distribution and level of response (PD20) for parents of infants in each of the four groups are shown in Figure 3Figure 3Doses of Histamine That Provoked a Decrease of 20 Percent in the Forced Expiratory Volume in One Second in 75 Parents of Infants in the Four Groups (PD20).. There was no relation between the level of parental responsiveness to histamine and the infant's PC40.

For the group as a whole, a significant positive correlation was found between the maternal serum IgE level and the cord-serum IgE level (P<0.01). When each family-history group was analyzed separately, however, this relation was not observed. No significant correlations were found between the maternal serum IgE level and the infant's value for PC40 or between the cord-serum IgE level and PC40, either for the entire group of 63 infants or for the four family-history groups. There were no significant differences among the groups in either maternal venous serum IgE levels or cord-serum IgE levels (Fig. 4Figure 4IgE Levels in Cord and Maternal Venous Serum, According to Family-History Group.).

Discussion

The results of this study demonstrate that airway responsiveness to inhaled histamine is present in many normal, healthy infants soon after birth. We also found that the level of airway responsiveness in early life was increased if there was a family history of asthma, parental smoking, or both.

The development of techniques for assessing airway function in infants has made possible the study of airway responsiveness in the first two years of life, a period during which children had not been studied previously. Prendiville et al.3 showed that infants with recurrent wheeziness were responsive to inhaled histamine. This study was followed by the work of Tepper with methacholine,4 Geller et al. with cold, dry air,5 and Le Souëf et al. with histamine,6 which demonstrated that the airways of normal, healthy, asymptomatic infants were responsive to the same bronchoconstrictive agents routinely used in testing older children and adults. In these studies,4 5 6 infants were studied well into the first year of life, at mean ages of 8.1 months, 5.6 months, and 7.8 months, respectively. We wished to investigate whether airway responsiveness could be detected in very early infancy. Therefore, in this study we assessed infants at a mean age of 4 1/2 weeks, with some only 2 weeks old. A response to histamine was observed in all but 5 of the 63 infants. This finding indicates clearly that airway responsiveness is present very early in life, and it is not unreasonable to suggest that it may be present from birth.

Another reason for studying infants so early in life is that with increasing age the effect of a number of environmental insults to the airway is likely to increase. These irritants include exposure to cigarette smoke, exposure to allergens, and respiratory tract infections. These respiratory insults are known to increase airway responsiveness in older children and adults,1 and it is possible that they also affect airway responsiveness in infants. Therefore, when airway responsiveness is assessed in middle-to-late infancy, exposure to these environmental factors makes it difficult to extrapolate the initial level of airway responsiveness. Studying infants soon after birth should help to minimize, but will not eliminate, this problem.

We found that the level of responsiveness to histamine in infants was related to the presence or absence of a family history of asthma. This finding suggests that the initial level of airway responsiveness may be genetically determined. A genetic effect on airway responsiveness in later life has been established in studies of twins16 and of the families of persons with asthma.17 18 19 Studies have shown a higher concordance for asthma and atopy in monozygotic twins than in dizygotic twins.16 Furthermore, other studies have shown a significant relation between a history of asthma in parents and siblings and the development of asthma in early childhood.18 , 19 Our study indicates that a history of asthma in primary or secondary relatives, or both, influences the level of airway responsiveness at an early age.

We also found that airway responsiveness was increased in infants whose parents reported smoking during the pregnancy. Population-based studies of airway responsiveness have found an increase in airway sensitivity among children with asthma whose mothers smoked. Martinez et al.20 recently reported that exposure to tobacco smoke enhanced airway responsiveness in nine-year-old children; bronchial hyperresponsiveness was present in 70 percent of the children whose mothers smoked regularly during the pregnancy, but in only 29 percent of the children whose parents did not smoke during the pregnancy. Since these investigators did not find an overall association between airway responsiveness and current smoking by the mother, they suggested that fetal exposure to tobacco smoke may have had an important effect on airway responsiveness. Our study also demonstrates an association between parental smoking and the level of airway responsiveness in early infancy, although we are unable to separate the effects of prenatal and postnatal exposure to cigarette smoke. The effect of continued postnatal exposure on the base-line level of responsiveness and on the subsequent development of the symptoms of asthma is unknown. Moreover, we have not reported the amount of smoking, since it is widely recognized that the relation between the level of smoking reported by parents and the actual level of passive smoking by the fetus or infant is poor because of underreporting by parents, variations in ventilation in rooms and houses, and differences in the distance between the smoker and the infant.

Base-line lung function, expressed as a percentage of the predicted VmaxFRC,15 did not differ significantly among the four family-history groups, and no correlation was observed between base-line lung function and PC40. These findings are in agreement with those of studies in humans21 22 23 and animals24 , 25 that have suggested that the caliber of the airway at base line may not be an important factor in responsiveness.

Many studies have been conducted to determine the usefulness of serum IgE levels measured at birth and during infancy in predicting the development of atopic diseases, including asthma, and skin reactivity.26 27 28 29 30 31 These studies have indicated that a high IgE level is, in general, associated with atopy; however, all investigators have noted a wide range of IgE levels, with considerable overlap, between subjects with and without atopy. In our study, the infant's IgE level did not predict the initial level of airway responsiveness or skin reactivity, either for the group as a whole or for the four family-history groups individually. This lack of relation between atopic markers and airway responsiveness may be due to the fact that the infants were assessed before sufficient exposure to allergens had occurred. Bryant and Burns,32 in a study of the relation between atopic status and airway responsiveness to histamine, found no correlations between serum IgE levels and the number of positive skin-prick responses or the level of airway responsiveness in a group of adults with asthma and normal adults.

Correlations have previously been found both between IgE levels in parents and those in infants26 and between a family history of atopic diseases and the infant's IgE level.26 27 28 29 30 31 , 33 We found a significant positive correlation between maternal and cord-serum IgE levels for the group as a whole, but these two measures did not discriminate among infants with different family histories. These data suggest that allergic markers are not strongly related to the initial level of airway responsiveness at this age. Because these infants are part of a longitudinal study, the potential role and relative importance of these immunologic markers may be clarified as they grow older.

In summary, we found that airway responsiveness to inhaled histamine was often present in normal, healthy, asymptomatic infants early in life. We suggest that responsiveness is present from birth and is determined both by inheritance and by exposure to parental cigarette smoking. The relation of this initial level of airway responsiveness to future levels of responsiveness, respiratory problems, and immunologic markers after exposure to environmental insults during infancy remains to be clarified.

Supported by the National Health and Medical Research Council (Project No. 880910).

We are indebted to the staff of the prenatal clinic and the State Health Pathology Laboratory at Osborne Park Hospital for their assistance; to Karen Krska of the Clinical Immunology Research Unit, Princess Margaret Hospital for Children, for performing the IgE assays; and to Amanda Reese, B.Sc, and Debra Turner, B.Sc.(Hons.), Department of Respiratory Medicine, for technical assistance.

Source Information

From the Department of Respiratory Medicine (S.Y., P.N.L., G.C.G., S.M.S., L.I.L.) and the Clinical Immunology Research Unit (K.J.T.), Princess Margaret Hospital for Children, Perth, Australia. Address reprint requests to Miss Young at the Department of Respiratory Medicine, P.O. Box D 184, Perth 6001, W.A., Australia.

References

References

  1. 1

    Boushey HA, Holtzman MJ, Sheller JR, Nadel JA. Bronchial hyper-reactivity . Am Rev Respir Dis 1980; 121:389–413.
    Web of Science | Medline

  2. 2

    Taussig LM, Landau LI. Godfrey S, Arad I. Determinants of forced expiratory flow in newborn infants . J Appl Physiol 1982; 53:1220–7.
    Web of Science | Medline

  3. 3

    Prendiville A, Green S, Silverman M. Bronchial responsiveness to histamine in wheezy infants . Thorax 1987; 42:92–9.
    CrossRef | Web of Science | Medline

  4. 4

    Tepper RS. Airway reactivity in infants: a positive response to methacholine and metaproterenol . J Appl Physiol 1987; 62:1155–9.
    Web of Science | Medline

  5. 5

    Geller DE, Morgan WJ, Cota KA, Wright achéal, Taussig LM. Airway responsiveness to cold, dry air in normal infants . Pediatr Pulmonol 1988; 4:90–7.
    CrossRef | Web of Science | Medline

  6. 6

    LeSouëf PN, GeelhoedGC, Turner DJ, Morgan SEG, Landau LI. Response of normal infants to inhaled histamine . Am Rev Respir Dis 1989; 139:62–6.
    CrossRef | Web of Science | Medline

  7. 7

    Silverman M, Wilson N. Bronchial responsiveness in children: a clinical view. In: Milner AD. Martin RJ, eds. Neonatal and pediatric respiratory medicine. London: Butterworth, 1985:161–89.

  8. 8

    Ferris BG. Epidemiology standardization project. II. Recommended respiratory disease questionnaires for use with adults and children in epidemiological research . Am Rev Respir Dis 1978; 118:Suppl:7–53.
    Web of Science | Medline

  9. 9

    Yan K, Salome C, Woolcock AJ. Rapid method for measurement of bronchial responsiveness . Thorax 1983; 38:760–5.
    CrossRef | Web of Science | Medline

  10. 10

    Turner KJ, Holt BJ, Holt PG. In vitro synthesis of IgE by human peripheral blood leucocytes: relationship to serum titre of leucocyte donor . Clin Exp Immunol 1981;43:458–62.
    Web of Science | Medline

  11. 11

    Stick SM, Turner DJ, Landau LI, Lesouëf PN. Histamine challenge tests in infants: repeatability and comparison with methacholine . Am Rev Respir Dis 1990; 141:Suppl:A283. abstract.

  12. 12

    The Mann-Whitney test. In: Zar JH. Biostatistical analysis. Englewood Cliffs, N.J.: Prentice-Hall, 1974:109–13.

  13. 13

    Gardner MJ, Gardner SB, Winter PD. Confidence interval analysis (CIA). London: British Medical Journal, 1989 (microcomputer program)

  14. 14

    Campbell MJ, Gardner MJ. Calculating confidence intervals for some nonparametric analyses. In: Gardner MJ, Altman DE, eds. Statistics with confidence — confidence intervals and statistical guidelines. London: British Medical Journal 1989:71–6.

  15. 15

    Tepper RS, Morgan WJ, Cota K. Wright A, Taussig LM. Physiologic growth and development of the lung during the first year of life . Am Rev Respir Dis 1986; 134:513–9.
    Web of Science | Medline

  16. Erratum, Am Rev Respir Dis 1987; 136:800.
    CrossRef

  17. 16

    Edfors-Lubs ML. Allergy in 7000 twin pairs . Acta Allergol 1971; 26:249–85.
    Medline

  18. 17

    Schwartz M. Heredity in bronchial asthma: a clinical and genetic study of 191 asthma probands and 50 probands with Baker's asthma . Acta Allergol 1952; 5:Suppl 2:1–288.
    Medline

  19. 18

    Sibbald B, Horn ME, Brain EA, Gregg I. Genetic factors in childhood asthma . Thorax 1980; 35:671–4.
    CrossRef | Web of Science | Medline

  20. 19

    Horwood LJ, Fergusson DM, Shannon FT. Social and familial factors in the development of early childhood asthma . Pediatrics 1985; 75:859–68.
    Web of Science | Medline

  21. 20

    Martinez FD, Antognoni G, Macri F, et al. Parental smoking enhances bronchial responsiveness in nine-year-old children . Am Rev Respir Dis 1988; 138:518–23.
    Web of Science | Medline

  22. 21

    Cade JF, Pain MCF. Role of bronchial reactivity in the aetiology of asthma . Lancet 1971; 2:186–8.
    CrossRef | Web of Science | Medline

  23. 22

    Rubinfeld AR, Pain MCF. Relationship between bronchial reactivity, airway caliber, and seventy of asthma . Am Rev Respir Dis 1977; 115:381–7.
    Web of Science | Medline

  24. 23

    Orehek J, Gayrard P, Smith AP, Grimaud C, Charpin J. Airway response to carbachol in normal and asthmatic subjects: distinction between bronchial sensitivity and reactivity . Am Rev Respir Dis 1977; 115:937–43.
    Web of Science | Medline

  25. 24

    DeKock MA, Nadel JA, Zwi S, Colebatch HJH, Olsen CR. New method for perfusing bronchial arteries: histamine bronchoconstriction and apnea . J Appl Physiol 1966; 21:185–94.
    Web of Science | Medline

  26. 25

    Benson MK, Graf PD. Bronchial reactivity: interaction between vagal stimulation and inhaled histamine . J Appl Physiol 1977; 43:643–7.
    Web of Science | Medline

  27. 26

    Gerrard JW, Home S, Vickers P, et al. Serum IgE levels in parents and children . J Pediatr 1974; 5:660–3.

  28. 27

    Kjellman N-IM. Predictive value of high IgE levels in children . Acta Paediatr Scand 1976;65:465–71.
    CrossRef | Web of Science | Medline

  29. 28

    Kjellman N-IM, Johansson SGO. IgE and atopic allergy in newborns and infants with a family history of atopic disease . Acta Paediatr Scand 1976; 65:601–7.
    CrossRef | Web of Science | Medline

  30. 29

    Orgel HA, Kemp JP, Meltzer EO, Hamburger RN. Atopy and IgE in a pediatric allergy practice . Ann Allergy 1977; 39:161–8.
    Medline

  31. 30

    Saarinen UM, Juntunen K, Kajosaari M, Bjorksten F. Serum immunoglobulin E in atopic and non-atopic children aged 6 months to 5 years: a follow-up study . Acta Paediatr Scand 1982; 71:489–94.
    CrossRef | Web of Science | Medline

  32. 31

    Croner S, Kjellman N-IM, Eriksson B, Roth A. IgE screening in 1701 newborn infants and the development of atopic disease during infancy . Arch Dis Child 1982;57:364–8.
    CrossRef | Web of Science | Medline

  33. 32

    Bryant DH, Burns MW. The relationship between bronchial histamine reactivity and atopic status . Clin Allergy 1976; 6:373–81.
    CrossRef | Medline

  34. 33

    Geller-Bernstein G, Kenett R. Weisglass L, Tsur S, Lahav M. Levin S. Atopic babies with wheezy bronchitis . Allergy 1987; 42:85–91.
    CrossRef | Web of Science | Medline

Citing Articles (127)

Citing Articles

  1. 1

    Indra Narang, Andrew Bush. (2012) Early origins of chronic obstructive pulmonary disease. Seminars in Fetal and Neonatal Medicine
    CrossRef

  2. 2

    Miki Kanoh, Yoshitaka Kaneita, Megumi Hara, Shohei Harada, Yasuhiro Gon, Hiroshi Kanamaru, Takashi Ohida. (2011) Longitudinal study of parental smoking habits and development of asthma in early childhood. Preventive Medicine
    CrossRef

  3. 3

    Robyn T. Cohen, Anusha Madadi, Morey A. Blinder, Michael R. DeBaun, Robert C. Strunk, Joshua J. Field. (2011) Recurrent, severe wheezing is associated with morbidity and mortality in adults with sickle cell disease. American Journal of Hematology 86:9, 756-761
    CrossRef

  4. 4

    Catherine M. Hayden, Guicheng Zhang, Parveenjeet K. Judge, Siew-Kim Khoo, Ingrid A. Laing, Stephen W. Turner, Jack Goldblatt, Patrick G. Holt, Peter N. Le Souëf. (2011) Regulatory role of IL10 genetic variations in determining allergen-induced TH2 cytokine responses in children. Journal of Allergy and Clinical Immunology 128:1, 237-239.e8
    CrossRef

  5. 5

    Maximilian Schmid, Gregor Kasprian, Julian Marschalek, Angela Posch, Csilla Balassy, Daniela Prayer. (2011) Maternal smoking and fetal lung volume-an in utero MRI investigation. Prenatal Diagnosis 31:5, 491-495
    CrossRef

  6. 6

    Bong-Seong Kim, Hyun-Seung Jin, Hyo-Bin Kim, So-Yeon Lee, Ja-Hyung Kim, Ji-Won Kwon, Byoung-Ju Kim, Jinho Yu, Sunmi Yoo, Soo-Jong Hong. (2010) Airway hyperresponsiveness is associated with total serum immunoglobulin E and sensitization to aeroallergens in Korean adolescents. Pediatric Pulmonology 45:12, 1220-1227
    CrossRef

  7. 7

    Dae Jin Song. (2010) Environmental tobacco smoke and childhood asthma. Korean Journal of Pediatrics 53:2, 121
    CrossRef

  8. 8

    A. Pietinalho, A. Pelkonen, P. Rytil. (2009) Linkage between smoking and asthma. Allergy 64:12, 1722-1727
    CrossRef

  9. 9

    Hans Michael Haitchi, David J.P. Bassett, Fabio Bucchieri, Xiufeng Gao, Robert M. Powell, Neil A. Hanley, David I. Wilson, Stephen T. Holgate, Donna E. Davies. (2009) Induction of a disintegrin and metalloprotease 33 during embryonic lung development and the influence of IL-13 or maternal allergy. Journal of Allergy and Clinical Immunology 124:3, 590-597.e11
    CrossRef

  10. 10

    Maria Cheraghi, Sundeep Salvi. (2009) Environmental tobacco smoke (ETS) and respiratory health in children. European Journal of Pediatrics 168:8, 897-905
    CrossRef

  11. 11

    Joelene A. Bizzintino, Siew-Kim Khoo, Guicheng Zhang, Andrew C. Martin, Kristina Rueter, Gary C. Geelhoed, Jack Goldblatt, Ingrid A. Laing, Peter N. Le Souëf, Catherine M. Hayden. (2009) Leukotriene pathway polymorphisms are associated with altered cysteinyl leukotriene production in children with acute asthma. Prostaglandins, Leukotrienes and Essential Fatty Acids 81:1, 9-15
    CrossRef

  12. 12

    M. Ali, G. Zhang, W. R. Thomas, C. J. McLean, J. A. Bizzintino, I. A. Laing, A. C. Martin, J. Goldblatt, P. N. Le Souëf, C. M. Hayden. (2009) Investigations into the role of ST2 in acute asthma in children. Tissue Antigens 73:3, 206-212
    CrossRef

  13. 13

    Hans Bisgaard, Lotte Loland, Klaus K. Holst, Christian B. Pipper. (2009) Prenatal determinants of neonatal lung function in high-risk newborns. Journal of Allergy and Clinical Immunology 123:3, 651-657.e4
    CrossRef

  14. 14

    Andrew Bush. 2009. Pediatric AsthmaHow Early Life Events Cause Lifelong Respiratory Disease. , 791-821.
    CrossRef

  15. 15

    Christina E. Ciaccio, Jay M. Portnoy. (2008) Strategies for primary prevention of atopy in children. Current Allergy and Asthma Reports 8:6, 493-499
    CrossRef

  16. 16

    Robert S. Tepper, Conrado J. Llapur, Marcus H. Jones, Christina Tiller, Cathy Coates, Risa Kimmel, Jeffrey Kisling, Barry Katz, Yan Ding, Nancy Swigonski. (2008) Expired nitric oxide and airway reactivity in infants at risk for asthma. Journal of Allergy and Clinical Immunology 122:4, 760-765
    CrossRef

  17. 17

    W. Gerald Teague. (2008) Food allergen sensitization as a determinant of disturbed airway function in young infants: First step on the path to persistent asthma?. Journal of Allergy and Clinical Immunology 122:4, 766-767
    CrossRef

  18. 18

    Louis I. Landau. (2008) Tobacco smoke exposure and tracking of lung function into adult life. Paediatric Respiratory Reviews 9:1, 39-44
    CrossRef

  19. 19

    Louis I. Landau, Lynn M. Taussig. 2008. Early Childhood Origins and Economic Impact of Respiratory Disease Throughout Life. , 1-7.
    CrossRef

  20. 20

    Georgette Stern, Philipp Latzin, Cindy Thamrin, Urs Frey. (2007) How can we measure the impact of pollutants on respiratory function in very young children? Methodological aspects. Paediatric Respiratory Reviews 8:4, 299-304
    CrossRef

  21. 21

    Anthony D. Milner, Harish Rao, Anne Greenough. (2007) The effects of antenatal smoking on lung function and respiratory symptoms in infants and children. Early Human Development 83:11, 707-711
    CrossRef

  22. 22

    Alicia Armentia, Borja Bartolomé, Miguel Puyo, Carmen Paredes, Silvia Calderón, Teresa Asensio, Valentín del Villar. (2007) Tobacco as an allergen in bronchial disease. Annals of Allergy, Asthma & Immunology 98:4, 329-336
    CrossRef

  23. 23

    S. W. Turner, T. Heaton, J. Rowe, D. Suriyaarachchi, M. Serralha, B. J. Holt, P. J. Franklin, S. M. Stick, J. Goldblatt, P. D. Sly, P. N. le Souëf, P. G. Holt. (2007) Early-onset atopy is associated with enhanced lymphocyte cytokine responses in 11-year-old children. Clinical & Experimental Allergy 37:3, 371-380
    CrossRef

  24. 24

    Javier Mallol, José A Castro-Rodriguez, Eliana Cortez. (2007) Effects of active tobacco smoking on the prevalence of asthma-like symptoms in adolescents. International Journal of COPD 2:1, 65-69
    CrossRef

  25. 25

    G. Zhang, C.M. Hayden, S.-K. Khoo, I.A. Laing, S. Turner, L. Landau, J. Goldblatt, P.N. Le Souëf. (2006) Association of haplotypes of β2-adrenoceptor polymorphisms with lung function and airway responsiveness in a pediatric cohort. Pediatric Pulmonology 41:12, 1233-1241
    CrossRef

  26. 26

    Peter N Le Souëf. (2006) Variations in genetic influences on the development of asthma throughout childhood, adolescence and early adult life. Current Opinion in Allergy and Clinical Immunology 6:5, 317-322
    CrossRef

  27. 27

    Mari K. Hyvärinen, Anne Kotaniemi-Syrjänen, Tiina M. Reijonen, Kaj Korhonen, Vesa Kiviniemi, Matti Korppi. (2006) Responses to inhaled bronchodilators in infancy are not linked with asthma in later childhood. Pediatric Pulmonology 41:5, 420-427
    CrossRef

  28. 28

    Sooky Lum, Georg Hülskamp, Peter Merkus, Eugenio Baraldi, Ward Hofhuis, Janet Stocks. (2006) Lung Function Tests in Neonates and Infants with Chronic Lung Disease: Forced Expiratory Maneuvers. Pediatric Pulmonology 41:3, 199-214
    CrossRef

  29. 29

    Andrew Bush. (2006) Clinical Trials Research in Pediatrics. Pediatric Drugs 8:5, 271-277
    CrossRef

  30. 30

    R.C. Vickery. 2005. Leukemias. .
    CrossRef

  31. 31

    R.C. Vickery. 2005. Bronchial Asthma. .
    CrossRef

  32. 32

    Gert S. Maritz, Colin J. Morley, Richard Harding. (2005) Early developmental origins of impaired lung structure and function. Early Human Development 81:9, 763-771
    CrossRef

  33. 33

    Andrew Bush. (2005) Asthma research: The real action is in children. Paediatric Respiratory Reviews 6:2, 101-110
    CrossRef

  34. 34

    S. W. Turner, L. J. Palmer, N. A. Gibson, P. J. Rye, J. Goldblatt, L. I. Landau, P. N. Le Souef. (2005) The effect of age on the relationship between birth order and immunoglobulin E sensitization. Clinical <html_ent glyph="@amp;" ascii="&"/> Experimental Allergy 35:5, 630-634
    CrossRef

  35. 35

    T Heaton, J Rowe, S Turner, RC Aalberse, N de Klerk, D Suriyaarachchi, M Serralha, BJ Holt, E Hollams, S Yerkovich, K Holt, PD Sly, J Goldblatt, PLe Souef, PG Holt. (2005) An immunoepidemiological approach to asthma: identification of in-vitro T cell response patterns associated with different wheezing phenotypes in children. The Lancet 365:9454, 142-149
    CrossRef

  36. 36

    Elisabeth M.W. Kooi, Elianne J.L.E. Vrijlandt, H. Marike Boezen, Eric J. Duiverman. (2004) Children with smoking parents have a higher airway resistance measured by the interruption technique. Pediatric Pulmonology 38:5, 419-424
    CrossRef

  37. 37

    KENNETH SANDBERG, STANLEY D. POOLE, ASHRAF HAMDAN, PATRICK ARBOGAST, H??KAN W. SUNDELL. (2004) Altered Lung Development after Prenatal Nicotine Exposure in Young Lambs. Pediatric Research 56:3, 432-439
    CrossRef

  38. 38

    Peter W Heymann, Holliday T Carper, Deborah D Murphy, Thomas A.E Platts-Mills, James Patrie, Anne P McLaughlin, Elizabeth A Erwin, Marcus S Shaker, Martha Hellems, Jehanna Peerzada, Frederick G Hayden, Tina K Hatley, Rachel Chamberlain. (2004) Viral infections in relation to age, atopy, and season of admission among children hospitalized for wheezing. Journal of Allergy and Clinical Immunology 114:2, 239-247
    CrossRef

  39. 39

    Nicola M. Wilson, Jane R. Lamprill, Judith C.W. Mak, Jane R. Clarke, Andrew Bush, Michael Silverman. (2004) Symptoms, lung function, and ?2-adrenoceptor polymorphisms in a birth cohort followed for 10 years. Pediatric Pulmonology 38:1, 75-81
    CrossRef

  40. 40

    Vibeke Backer, Steen Nepper-Christensen, Celeste Porsbjerg, Marie-Louise von Linstow, Philip Reersted. (2004) Respiratory symptoms in Greenlanders living in Greenland and Denmark: a population-based study. Annals of Allergy, Asthma & Immunology 93:1, 76-82
    CrossRef

  41. 41

    S. W. Turner, S.-K. Khoo, I. A. Laing, L. J. Palmer, N. A. Gibson, P. Rye, L. I. Landau, J. Goldblatt, P. N. Le Souef. (2004) beta2 adrenoceptor Arg16Gly polymorphism, airway responsiveness, lung function and asthma in infants and children. Clinical <html_ent glyph="@amp;" ascii="&"/> Experimental Allergy 34:7, 1043-1048
    CrossRef

  42. 42

    Clare S. Murray, Ashley Woodcock, Frazer I. Smillie, Greg Cain, Patricia Kissen, Adnan Custovic, . (2004) Tobacco smoke exposure, wheeze, and atopy. Pediatric Pulmonology 37:6, 492-498
    CrossRef

  43. 43

    Donald Payne, Andrew Bush. (2004) Phenotype-specific treatment of difficult asthma in children. Paediatric Respiratory Reviews 5:2, 116-123
    CrossRef

  44. 44

    R. Antonucci, P. Contu, A. Porcella, C. Atzeni, S. Chiappe. (2004) Intrauterine smoke exposure: a new risk factor for bronchopulmonary dysplasia?. Journal of Perinatal Medicine 32:3, 272-277
    CrossRef

  45. 45

    LK Dotterud, JO Odland, ES Falk. (2004) Atopic dermatitis and respiratory symptoms in Russian and northern Norwegian school children: a comparison study in two arctic areas and the impact of environmental factors. Journal of the European Academy of Dermatology and Venereology 18:2, 131-136
    CrossRef

  46. 46

    Lesley Lowe, Adnan Custovic, Ashley Woodcock. (2004) Childhood asthma. Current Allergy and Asthma Reports 4:2, 159-165
    CrossRef

  47. 47

    Andrew Bush. (2004) Phenotype specific treatment of asthma in childhood. Paediatric Respiratory Reviews 5, S93-S101
    CrossRef

  48. 48

    J. J. K. Jaakkola, M. Gissler. (2004) Maternal Smoking in Pregnancy, Fetal Development, and Childhood Asthma. American Journal of Public Health 94:1, 136-140
    CrossRef

  49. 49

    Janet STOCKS, Carol DEZATEUX. (2003) The effect of parental smoking on lung function and development during infancy. Respirology 8:3, 266-285
    CrossRef

  50. 50

    May Ali, Siew-Kim Khoo, Stephen Turner, Stephen Stick, Peter Le Souef, Peter Franklin. (2003) NOS1 polymorphism is associated with atopy but not exhaled nitric oxide levels in healthy children. Pediatric Allergy and Immunology 14:4, 261-265
    CrossRef

  51. 51

    Robert Welliver. 2003. Does Respiratory Syncytial Virus Cause Asthma?. .
    CrossRef

  52. 52

    Moira CHAN-YEUNG, Helen DIMICH-WARD. (2003) Respiratory health effects of exposure to environmental tobacco smoke. Respirology 8:2, 131-139
    CrossRef

  53. 53

    Peter Le Souef. (2002) Prediction of asthma in children at 6 and 12 years of age: Perth infant asthma follow-up study. Pediatric Allergy and Immunology 13:s15, 44-46
    CrossRef

  54. 54

    Tamy Shohat, Manfred S. Green, Yael Davidson, Irit Livne, Rami Tamir, Ben-Zion Garty. (2002) Differences in the prevalence of asthma and current wheeze between Jews and Arabs: results from a national survey of schoolchildren in Israel. Annals of Allergy, Asthma & Immunology 89:4, 386-392
    CrossRef

  55. 55

    Susanne Lau, Renate Nickel, Bodo Niggemann, Christoph Grüber, Christine Sommerfeld, Sabina Illi, Michael Kulig, Johannes Forster, Ulrich Wahn. (2002) The development of childhood asthma: lessons from the German Multicentre Allergy Study (MAS). Paediatric Respiratory Reviews 3:3, 265-272
    CrossRef

  56. 56

    Vibeke Backer, Steen Nepper-Christensen, Charlotte Suppli Ulrik, Marie-Louise von Linstow, Celeste Porsbjerg. (2002) Factors associated with asthma in young Danish adults. Annals of Allergy, Asthma & Immunology 89:2, 148-154
    CrossRef

  57. 57

    Lesley Lowe, Clare S Murray, Adnan Custovic, Bridget M Simpson, Patricia M Kissen, Ashley Woodcock. (2002) Specific airway resistance in 3-year-old children: a prospective cohort study. The Lancet 359:9321, 1904-1908
    CrossRef

  58. 58

    Andrew Bush. (2002) Paediatric Problems of Cough. Pulmonary Pharmacology & Therapeutics 15:3, 309-315
    CrossRef

  59. 59

    A. Host, S. Halken. (2002) Can we apply clinical studies to real life?Evidence-based recommendations from studies on development of allergic diseases and allergy prevention. Allergy 57:5, 389-397
    CrossRef

  60. 60

    H. P. Van Bever, K. N. Desager, M. Hagendorens. (2002) Critical evaluation of prognostic factors in childhood asthma. Pediatric Allergy and Immunology 13:2, 77-83
    CrossRef

  61. 61

    Lee Maddox, David A. Schwartz. (2002) T HE P ATHOPHYSIOLOGY OF A STHMA. Annual Review of Medicine 53:1, 477-498
    CrossRef

  62. 62

    L.I. Landau. (2001) Parental smoking: asthma and wheezing illnesses in infants and children. Paediatric Respiratory Reviews 2:3, 202-206
    CrossRef

  63. 63

    AJ Campbell, BC Galland, DPG Bolton, BJ Taylor, RM Sayers, SM Williams. (2001) Ventilatory responses to rebreathing in infants exposed to maternal smoking. Acta Paediatrica 90:7, 793-800
    CrossRef

  64. 64

    Dennis R. Ownby. (2001) Pediatric asthma and development of atopy. Current Opinion in Allergy and Clinical Immunology 1:2, 125-126
    CrossRef

  65. 65

    Peter Le Souef. (2000) Infant lung function, bronchial responsiveness and the developmentof asthma. Pediatric Allergy and Immunology 11:Suppl. 13, 15-18
    CrossRef

  66. 66

    S. Halken, A. Host. (2000) The lessons of noninterventional and interventional prospective studies on the development of atopic disease during childhood. Allergy 55:9, 793-802
    CrossRef

  67. 67

    A. Bush. (2000) Nosing out the future asthmatic?. Allergy 55:8, 685-687
    CrossRef

  68. 68

    Sally Young, Duane L. Sherrill, Jacqueline Arnott, Dean Diepeveen, Peter N. LeSouf, Louis I. Landau. (2000) Parental factors affecting respiratory function during the first year of life. Pediatric Pulmonology 29:5, 331-340
    CrossRef

  69. 69

    Matthew Y. Chang, Angela D. Hogan, Gary P. Rakes, Jim Mark Ingram, Gates E. Hoover, Thomas A.E. Platts-Mills, Peter W. Heymann. (2000) Salivary cotinine levels in children presenting with wheezing to an emergency department. Pediatric Pulmonology 29:4, 257-263
    CrossRef

  70. 70

    Jesse P. Joad. (2000) SMOKING AND PEDIATRIC RESPIRATORY HEALTH. Clinics in Chest Medicine 21:1, 37-46
    CrossRef

  71. 71

    GERALD REESE, WENDELL N. COLBERG, JANE M. EL-DAHR, MARJORIE L. McCANTS, SAMUEL B. LEHRER. (2000) Children with Acute Asthma: IgE Antibody Reactivities to Fungi, House Dust Mites, Cockroaches, and Other Indoor Allergens. Pediatric Asthma, Allergy & Immunology 14:1, 59-67
    CrossRef

  72. 72

    Tina V. Hartert, R. Stokes Peebles. (2000) Epidemiology of asthma: the year in review. Current Opinion in Pulmonary Medicine 6:1, 4-9
    CrossRef

  73. 73

    Young Yull Koh, Jin Hwa Jeong, Chang Keun Kim, Yoon Keun Kim, Young Koo Jee, Sang Heon Cho, Kyung Up Min, You Young Kim. (2000) Atopic Status and Level of Bronchial Responsiveness in Parents of Children with Acute Bronchiolitis. Journal of Asthma 37:8, 709-717
    CrossRef

  74. 74

    Ramsay, Hayden, Tiller, Burton, Goldblatt, Lesouef. (1999) Polymorphisms in the beta2-adrenoreceptor gene are associated with decreased airway responsiveness. Clinical <html_ent glyph="@amp;" ascii="&"/> Experimental Allergy 29:9, 1195-1203
    CrossRef

  75. 75

    Karin C. Lodrup Carlsen, Kai-hakon Carlsen, Per Nafstad, Leiv Bakketeig. (1999) Perinatal risk factors for recurrent wheeze in early life. Pediatric Allergy and Immunology 10:2, 89-95
    CrossRef

  76. 76

    David A. Mrazek, Mary Klinnert, Patricia J. Mrazek, Amy Brower, David McCormick, Betsy Rubin, David Ikle, William Kastner, Gary Larsen, Ron Harbeck, James Jones. (1999) Prediction of early-onset asthma in genetically at-risk children. Pediatric Pulmonology 27:2, 85-94
    CrossRef

  77. 77

    Janet Stocks. (1999) Respiratory function testing in early childhood: Where have we come from and where are we going?. Pediatric Pulmonology 27:S18, 24-28
    CrossRef

  78. 78

    Russell J. Hopp. (1999) Recurrent Wheezing in Infants and Young Children: A Perspective. Journal of Asthma 36:7, 547-553
    CrossRef

  79. 79

    Wenzel. (1998) Factors determining the severity of asthma. Clinical <html_ent glyph="@amp;" ascii="&"/> Experimental Allergy 28:Suppl. 5, 119-125
    CrossRef

  80. 80

    N.I M. Kjellman. (1998) Prediction and prevention of atopic allergy. Allergy 53, 67-71
    CrossRef

  81. 81

    Eva Millqvist, Olle Löwhagen. (1998) Methacholine Provocations Do Not Reveal Sensitivity to Strong Scents. Annals of Allergy, Asthma & Immunology 80:5, 381-384
    CrossRef

  82. 82

    Albuquerque, Hayden, Palmer, Laing, Rye, Gibson, Burton, Goldblatt, LesouEF. (1998) Association of polymorphisms within the tumour necrosis factor (TNF) genes and childhood asthma. Clinical <html_ent glyph="@amp;" ascii="&"/> Experimental Allergy 28:5, 578-584
    CrossRef

  83. 83

    Clough. (1998) Phenotype stability in asthma and atopy in childhood. Clinical & Experimental Allergy 28:S1, 22-25
    CrossRef

  84. 84

    Le SouËf. (1998) Use of cohorts with extensive longitudinal data in investigating the molecular genetics of asthma. Clinical & Experimental Allergy 28:S1, 46-50
    CrossRef

  85. 85

    E. Norrman, P Plaschke, E. Björnsson, L. Rosenhall, B. Lundbäck, C. Jansson, N. Lindholm, G. Boman. (1998) Prevalence of bronchial hyper-responsiveness in the southern, central and northern parts of Sweden. Respiratory Medicine 92:3, 480-487
    CrossRef

  86. 86

    Jennifer M. Knight, Chrisoula Eliopoulos, Julia Klein, Mark Greenwald, Gideon Koren. (1998) Pharmacokinetic Predisposition to Nicotine from Environmental Tobacco Smoke: A Risk Factor for Pediatric Asthma. Journal of Asthma 35:1, 113-117
    CrossRef

  87. 87

    Emma Pereira, Jack Goldblatt, Peter Rye, Colin Sanderson, Peter Le Souëf. (1998) Mutation analysis of interleukin-5 in an asthmatic cohort. Human Mutation 11:1, 51-54
    CrossRef

  88. 88

    Anne Greenough, Bulend Yuksel, Sandhia Naik, Paul Cheeseman, Kypros H. Nicolaides. (1997) First trimester invasive procedures: Effects on symptom status and lung volume in very young children. Pediatric Pulmonology 24:6, 415-422
    CrossRef

  89. 89

    S. H. Arshad. (1997) Development of allergic disease in children. Clinical <html_ent glyph="@amp;" ascii="&"/> Experimental Allergy 27:11, 1231-1233
    CrossRef

  90. 90

    Susan Murin, Janet Hilbert, Sharon J. Reilly. (1997) Cigaret smoking and the lung. Clinical Reviews in Allergy & Immunology 15:3, 307-361
    CrossRef

  91. 91

    David P Joyce, Kenneth R Chapman, Meyer Balter, Steven Kestsen. (1997) Asthma and Allergy Avoidance Knowledge and Behavior in Postpartum Women. Annals of Allergy, Asthma & Immunology 79:1, 35-42
    CrossRef

  92. 92

    Bengt Björkstén. (1997) Environmental risk factors for atopy. Clinical Reviews in Allergy & Immunology 15:2, 125-143
    CrossRef

  93. 93

    Hanspeter Witschi, Jesse P. Joad, Kent E. Pinkerton. (1997) THE TOXICOLOGY OF ENVIRONMENTAL TOBACCO SMOKE. Annual Review of Pharmacology and Toxicology 37:1, 29-52
    CrossRef

  94. 94

    L. I. Landau. (1996) Bronchial hyperresponsiveness from infancy to adulthood: epidemiological aspects. Pediatric Allergy and Immunology 7:S9, 39-41
    CrossRef

  95. 95

    P. J. Sterk. (1996) Bronchial hyperresponsiveness: definition and terminology. Pediatric Allergy and Immunology 7:S9, 7-9
    CrossRef

  96. 96

    Louis I. Landau. (1996) Risks of developing asthma. Pediatric Pulmonology 22:5, 314-318
    CrossRef

  97. 97

    SM Stick, PR Burton, L Gurrin, PD Sly, PN LeSouëf. (1996) Effects of maternal smoking during pregnancy and a family history of asthma on respiratory function in newborn infants. The Lancet 348:9034, 1060-1064
    CrossRef

  98. 98

    T. Foucard. (1996) Aggressive treatment of childhood asthma with local steroids. Good or bad?. Allergy 51:6, 367-371
    CrossRef

  99. 99

    K Barber, Elizabeth Mussin, D Kay Taylor. (1996) Fetal Exposure to Involuntary Maternal Smoking and Childhood Respiratory Disease. Annals of Allergy, Asthma & Immunology 76:5, 427-430
    CrossRef

  100. 100

    Douglas Schaubel, Helen Johansen, Mrinal Dutta, Marie Desmeules, Allan Becker, Yang Mao. (1996) Neonatal Characteristics as Risk Factors for Preschool Asthma. Journal of Asthma 33:4, 255-264
    CrossRef

  101. 101

    R. M. L. Niven. (1995) A review of the medical evidence for a link between air pollution and asthma. The Environmentalist 15:4, 267-271
    CrossRef

  102. 102

    K.-H. Carlsen. (1995) Development of lower respiratory symptoms. Pediatric Allergy and Immunology 6:S7, 36-41
    CrossRef

  103. 103

    P. N. SOUEF. (1995) Asthma genetics studies in Western Australia. Clinical <html_ent glyph="@amp;" ascii="&"/> Experimental Allergy 25:s2, 26-28
    CrossRef

  104. 104

    A. J. W. Henderson, J. Arnott, S. Young, T. Warshawski, L. I. Landau, P. N. Lesouëf. (1995) The effect of inhaled adrenaline on lung function of recurrently wheezy infants less than 18 months old. Pediatric Pulmonology 20:1, 9-15
    CrossRef

  105. 105

    S. Halken, A. Høst, L. Nilsson, E. Taudorf. (1995) Passive smoking as a risk factor for development of obstructive respiratory disease and allergic sensitization. Allergy 50:2, 97-105
    CrossRef

  106. 106

    F Giffin, A Greenough, B Yuksel. (1995) Does a family history of atopy influence lung function at follow-up of infants born prematurely?. Acta Paediatrica 84:1, 17-21
    CrossRef

  107. 107

    Louis I. Landau. (1995) Natural history of childhood asthma. Pediatric Pulmonology 19:S11, 30-31
    CrossRef

  108. 108

    Malcolm R. Sears. (1995) Risk factors for airway hyperresponsiveness in childhood asthma. Pediatric Pulmonology 19:S11, 42-43
    CrossRef

  109. 109

    James Kay, Marek J. Mortimer, Ann G. Jaron. (1995) Do Both Paternal and Maternal Smoking Influence the Prevalence of Childhood Asthma? A Study into the Prevalence of Asthma in Children and the Effects of Parental Smoking. Journal of Asthma 32:1, 47-55
    CrossRef

  110. 110

    C. Delacourt, D. Labbé, A. Vassault, D. Brunet-Langot, J. Blic, P. Scheinmann. (1994) Sensitization to inhalant allergens in wheezing infants is predictive of the development of infantile asthma. Allergy 49:10, 843-847
    CrossRef

  111. 111

    E. Norrman, L. Rosenhall, L. Nyström, E. Jönsson, N. Stjernberg. (1994) Prevalence of positive skin prick tests, allergic asthma, and rhinoconjunctivitis in teenagers in northern Sweden. Allergy 49:10, 808-815
    CrossRef

  112. 112

    R. Meinert, T. Frischer, J. Kuehr. (1994) Assessing the effect of time-varying covariates in cross-sectional studies. Journal of Clinical Epidemiology 47:9, 983-991
    CrossRef

  113. 113

    N. M. WILSON. (1994) The significance of early wheezing. Clinical <html_ent glyph="@amp;" ascii="&"/> Experimental Allergy 24:6, 522-529
    CrossRef

  114. 114

    P. J. Helms. (1994) Wheezing infants. Clinical <html_ent glyph="@amp;" ascii="&"/> Experimental Allergy 24:2, 97-99
    CrossRef

  115. 115

    Jesse P. Joad, Kent E. Pinkerton, John M. Bric. (1993) Effects of sidestream smoke exposure and age on pulmonary function and airway reactivity in developing rats. Pediatric Pulmonology 16:5, 281-288
    CrossRef

  116. 116

    R. Kraemer, C. Wirz Sommer, S. Gschwend-Eigenmann, M. H. Schöni, B. M. Stadier. (1993) Interfering factors to sensitivity and specificity of bronchial reactivity in children. Pediatric Allergy and Immunology 4:4, 187-195
    CrossRef

  117. 117

    Sally Young, Gary C. Geelhoed, Stephen M. Stick, Louis I. Landau, Peter N. Lesouéuf. (1993) The effect of age on oxygen desaturation during histamine inhalation challenge in normal infants. Pediatric Pulmonology 16:3, 158-162
    CrossRef

  118. 118

    S. M. Stick, D. J. Turner, Peter N. Lesouéf. (1993) Lung function and bronchial challenges in infants: Repeatability of histamine and comparison with methacholine challenges. Pediatric Pulmonology 16:3, 177-183
    CrossRef

  119. 119

    T. Frischer, J. Kuehr, R. Meinert, W. Karmaus, R. Urbanek. (1993) Risk factors for childhood asthma and recurrent wheezy bronchitis. European Journal of Pediatrics 152:9, 771-775
    CrossRef

  120. 120

    T. H. Frischer, J. Kuehr, R. Meinert, W. Karmaus, R. Urbanek. (1993) Relationship between exposure to dust mite allergen and bronchial response to exercise in schoolchildren sensitized to dust mites. Pediatric Pulmonology 16:1, 13-18
    CrossRef

  121. 121

    Debra J. Turner, Peter D. Sly, Peter N. Lesouëf. (1993) Assessment of forced expiratory volume — time parameters in detecting histamine-induced bronchoconstriction in wheezy infants. Pediatric Pulmonology 15:4, 220-224
    CrossRef

  122. 122

    L. I. LANDAU. (1993) Evolution of asthma. Journal of Paediatrics and Child Health 29:1, 4-5
    CrossRef

  123. 123

    Th Frischer, J Kuehr, R Meinert, W Karmaus, R Barth, E Hermann-Kunz, R Urbanek. (1992) Relationship between low birth weight and respiratory symptoms in a cohort of primary school children. Acta Paediatrica 81:12, 1040-1041
    CrossRef

  124. 124

    Desforges, Jane F., , Larsen, Gary L., . (1992) Asthma in Children. New England Journal of Medicine 326:23, 1540-1545
    Full Text

  125. 125

    Gary L. Larsen. (1992) Airway responsiveness: New concepts and concerns. Pediatric Pulmonology 13:2, 69-70
    CrossRef

  126. 126

    L. I. Landau. (1992) Development of respiratory symptoms and bronchial hyperresponsiveness in infancy. Pediatric Allergy and Immunology 3:2, 61-65
    CrossRef

  127. 127

    P.N. Le Souëf. (1992) Validity of methods used to test airway responsiveness in children. The Lancet 339:8804, 1282-1284
    CrossRef